Ireland· IE-PA-EU/1/18/1266/007-012
Steglujan 15 mg/100 mg film-coated tablets
A sitagliptin and ertugliflozin product containing ertugliflozin l-pyroglutamic acid + sitagliptin phosphate monohydrate, registered in Ireland by Merck Sharp & Dohme BV. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Sitagliptin and ertugliflozin is registered in 10 of 19 countries.
Countries holding a registration under ATC A10BD24 (sitagliptin and ertugliflozin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Sitagliptin and ertugliflozin · ATC A10BD24
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Ertugliflozin l-pyroglutamic acid + Sitagliptin phosphate monohydrate
- Manufacturer
- Merck Sharp & Dohme BV
- Country
- Ireland (IE)
- ATC code
- A10BD24
- ATC class
- Sitagliptin and ertugliflozin
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/18/1266/007-012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sitagliptin and ertugliflozin in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b491802f-9968-4759-99c2-cb168899d810 GET /v1/drugs/b491802f-9968-4759-99c2-cb168899d810?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A10BD",
"A10BD24"
],
"strength": null,
"pa_number": "EU/1/18/1266/007-012",
"substances": [
"Ertugliflozin l-pyroglutamic acid",
"Sitagliptin phosphate monohydrate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "23/03/2018",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about sitagliptin and ertugliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.